SlideShare a Scribd company logo
Support. Don’t Punish
Discussing ReGen’s position on drug law reform
The campaign:
• International drug policy reform
• Increased focus on health and HR
• PWUD should not be criminalised
• Remove harsh punishments for
people at low end of drug trade
• End to use of death penalty
Discussing
ReGen’s
Position
Three broad options for reform:
• Depenalisation
• Decriminalisation
• Regulation (Legalisation)
Discussing
ReGen’s
Position
Depenalisation
• Possession & use remain
criminalised
• Individual still punished, but police
have discretion with penalty e.g.
infringement notices
Discussing
ReGen’s
Position
Decriminalisation
• Shift in punishment from criminal to
civil/administrative
• Increased accessibility of treatment
& support services
• Police can focus on production &
supply, rather than use/possession
• Enables expansion of HR measures
e.g. drug checking
Discussing
ReGen’s
Position
Legalisation
• Enables free or regulated markets
• Can be drug-specific e.g. cannabis
• Govt tax revenue (treatment funding)
• Capacity for quality control &
regulated supply
• Major impact on illicit markets
Discussing
ReGen’s
Position
Recent local developments:
• Canberra Drug Policy Summit
(http://www.drugpolicyreform.com.au/)
• Uniting NSW/ACT position
(http://sco.lt/6JDko5)
• UnitingCare Australia position
Where to
from here?

More Related Content

Similar to 2016 Support. Don't Punish presentation

Marijuana Legalization Policy Analysis
Marijuana Legalization Policy AnalysisMarijuana Legalization Policy Analysis
Marijuana Legalization Policy Analysis
Kenyon Hundley
 
Drug czar presentation
Drug czar presentationDrug czar presentation
Drug czar presentation
utahdaisylover
 

Similar to 2016 Support. Don't Punish presentation (20)

Susan Shepherd - Panel - Alternatives to the War on Drugs
Susan Shepherd - Panel - Alternatives to the War on DrugsSusan Shepherd - Panel - Alternatives to the War on Drugs
Susan Shepherd - Panel - Alternatives to the War on Drugs
 
Chapter 3
Chapter 3Chapter 3
Chapter 3
 
Rx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptageRx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptage
 
Goldberg Chapter 4
Goldberg Chapter 4Goldberg Chapter 4
Goldberg Chapter 4
 
Goldberg Chapter 4 Drugs & the Law
Goldberg Chapter 4 Drugs & the LawGoldberg Chapter 4 Drugs & the Law
Goldberg Chapter 4 Drugs & the Law
 
Marijuana Legalization Policy Analysis
Marijuana Legalization Policy AnalysisMarijuana Legalization Policy Analysis
Marijuana Legalization Policy Analysis
 
Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?
 
Rx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsRx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williams
 
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length PitchDrug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
 
Presentation: Prescription Medicines Reforms
Presentation: Prescription Medicines ReformsPresentation: Prescription Medicines Reforms
Presentation: Prescription Medicines Reforms
 
FLASCO ASCO Update
FLASCO ASCO UpdateFLASCO ASCO Update
FLASCO ASCO Update
 
GLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRYGLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRY
 
Drug czar presentation
Drug czar presentationDrug czar presentation
Drug czar presentation
 
Arcs presentation-recent-tga-activities
Arcs presentation-recent-tga-activitiesArcs presentation-recent-tga-activities
Arcs presentation-recent-tga-activities
 
2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...
2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...
2017 Federally Facilitated Marketplaces: Implications for Pharmaceutical and ...
 
Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manlove
 
Cannabis Science & Policy Summit - Day 2 - Reuter
Cannabis Science & Policy Summit - Day 2 - ReuterCannabis Science & Policy Summit - Day 2 - Reuter
Cannabis Science & Policy Summit - Day 2 - Reuter
 
Drugs & Society Chapter 3
Drugs & Society Chapter 3Drugs & Society Chapter 3
Drugs & Society Chapter 3
 
Orphan Drugs
Orphan DrugsOrphan Drugs
Orphan Drugs
 

More from Uniting ReGen

More from Uniting ReGen (20)

Addressing stigma: AOD Media Watch & sector advocacy
Addressing stigma: AOD Media Watch & sector advocacyAddressing stigma: AOD Media Watch & sector advocacy
Addressing stigma: AOD Media Watch & sector advocacy
 
Curran Place Adult & Mother Baby Withdrawal Service (08/06/17)
Curran Place Adult & Mother Baby Withdrawal Service (08/06/17)Curran Place Adult & Mother Baby Withdrawal Service (08/06/17)
Curran Place Adult & Mother Baby Withdrawal Service (08/06/17)
 
Recognising and responding to family violence within AOD treatment settings (...
Recognising and responding to family violence within AOD treatment settings (...Recognising and responding to family violence within AOD treatment settings (...
Recognising and responding to family violence within AOD treatment settings (...
 
Collaborative approaches to youth AOD and mental health support in Hume LGA
Collaborative approaches to youth AOD and mental health support in Hume LGACollaborative approaches to youth AOD and mental health support in Hume LGA
Collaborative approaches to youth AOD and mental health support in Hume LGA
 
Intensive outreach-based support for adults with longstanding, complex AOD is...
Intensive outreach-based support for adults with longstanding, complex AOD is...Intensive outreach-based support for adults with longstanding, complex AOD is...
Intensive outreach-based support for adults with longstanding, complex AOD is...
 
Implementing Clinical Governance in an AOD treatment service
Implementing Clinical Governance in an AOD treatment serviceImplementing Clinical Governance in an AOD treatment service
Implementing Clinical Governance in an AOD treatment service
 
How to critically analyse AOD issues in the media
How to critically analyse AOD issues in the mediaHow to critically analyse AOD issues in the media
How to critically analyse AOD issues in the media
 
Supporting safe social media practice in the AOD sector
Supporting safe social media practice in the AOD sectorSupporting safe social media practice in the AOD sector
Supporting safe social media practice in the AOD sector
 
Consumer Consultants at ReGen
Consumer Consultants at ReGenConsumer Consultants at ReGen
Consumer Consultants at ReGen
 
Cannabis: evolution of a withdrawal model - 2017 VAADA Conference
Cannabis: evolution of a withdrawal model - 2017 VAADA ConferenceCannabis: evolution of a withdrawal model - 2017 VAADA Conference
Cannabis: evolution of a withdrawal model - 2017 VAADA Conference
 
Staff & Consumer Social Media Practice: Findings & Next Steps (30 Nov 2016)
Staff & Consumer Social Media Practice: Findings & Next Steps (30 Nov 2016)Staff & Consumer Social Media Practice: Findings & Next Steps (30 Nov 2016)
Staff & Consumer Social Media Practice: Findings & Next Steps (30 Nov 2016)
 
Consumer participation @ ReGen: Transforming an organisation (11/05/16)
Consumer participation @ ReGen: Transforming an organisation (11/05/16)Consumer participation @ ReGen: Transforming an organisation (11/05/16)
Consumer participation @ ReGen: Transforming an organisation (11/05/16)
 
Tailoring programs and services to methamphetamine (Nov 15)
Tailoring programs and services to methamphetamine (Nov 15)Tailoring programs and services to methamphetamine (Nov 15)
Tailoring programs and services to methamphetamine (Nov 15)
 
Tailoring programs and services to methamphetamine (Sept 2015)
Tailoring programs and services to methamphetamine (Sept 2015)Tailoring programs and services to methamphetamine (Sept 2015)
Tailoring programs and services to methamphetamine (Sept 2015)
 
Torque Rehabilitation Program - program learnings & evaluation findings (#iAO...
Torque Rehabilitation Program - program learnings & evaluation findings (#iAO...Torque Rehabilitation Program - program learnings & evaluation findings (#iAO...
Torque Rehabilitation Program - program learnings & evaluation findings (#iAO...
 
Leadership in women within the scouting association
Leadership in women within the scouting associationLeadership in women within the scouting association
Leadership in women within the scouting association
 
Mental health alcohol & drug nurse practitioner collaborative
Mental health alcohol & drug nurse practitioner collaborativeMental health alcohol & drug nurse practitioner collaborative
Mental health alcohol & drug nurse practitioner collaborative
 
Consumer Participation
Consumer ParticipationConsumer Participation
Consumer Participation
 
Torque non-residential rehabilitation program evaluation
Torque non-residential rehabilitation program evaluationTorque non-residential rehabilitation program evaluation
Torque non-residential rehabilitation program evaluation
 
Sensible Specialist Service Responses to the Methamphetamine “Crisis”
Sensible Specialist Service Responses to the Methamphetamine “Crisis”Sensible Specialist Service Responses to the Methamphetamine “Crisis”
Sensible Specialist Service Responses to the Methamphetamine “Crisis”
 

Recently uploaded

Recently uploaded (20)

Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
 

2016 Support. Don't Punish presentation

Editor's Notes

  1. Acknowledge Country
  2. Campaign events happening all around the world to raise awareness and promote change. Punitive policies still common around the world (ref opposition to change by nations supporting death penalty at recent UNGASS), but lots of examples of change: International shifts on cannabis Canada looking to expand MSICs (beyond Vancouver) Ireland & Switzerland both committed to opening MSICs Vietnam recognising need to focus more on treatment and less on prison camps We’re comparatively fortunate in Aus to have had our Harm Minimisation policy framework in place for over 25 years, but we still have challenges too: Neither Vic Labor/Coalition will publicly consider MSIC Drug law reform at Federal level still some way off Opportunities to create our own campaign messages at the end
  3. Borrowing from Ginny’s work Each area very broad in terms of potential measures
  4. Limitations: High degree of variability – penalties applied depend on local practice Access to reduced penalty determined by location/individual officer
  5. Portugal (2001) the most famous example – focus on assessment of need and access to treatment. After 15 years, now has lowest rate of drug consumption in Europe; overdose rate 6x lower than EU average and significant drop in HIV transmission. Recent international moves to decriminalise cannabis
  6. Legalisation has the potential to have the highest benefit of the three reform options, but there is (currently) little research on its application in practice. Only recent examples with cannabis, none with other drugs. It’s also the least politically popular option. Few would argue for unregulated markets. Our experience with alcohol and tobacco highlight the need for strong regulation Common argument that removing penalties ‘sends the wrong message’ – recent data from Colorado shows state last lowest use of cannabis by young people in US. Regulation is tricky to implement (US & Uruguay examples), complicated by business practice when drug becomes ‘just another product’ – ‘Greenrush’
  7. Decrim was the consistent argument made at the Canberra summit (led by Richard Di Natale, but co-hosted by Labor’s Melissa Parke & Liberals’ Sharman Stone) Recognition that drug law reform is still some years away, but that there is a gradual shift in political support. Clear need for ongoing advocacy to help shift public and political opinion. Uniting NSW/ACT support for decrim of personal use/possession & increased priority for treatment/harm reduction funding. UnitingCare Australia has approved similar position but is yet to release it. We’ve been given permission by the former National Director to say whatever we want in our own position statement.